Dosage and administration
Cattle ....... 500 mL/800-1000 lbs body weight. For intravenous administration only. Solution should be warmed to body temperature and administered slowly using aseptic precautions.
Cattle ....... 500 mL/800-1000 lbs body weight. For intravenous administration only. Solution should be warmed to body temperature and administered slowly using aseptic precautions.
Store between 15 degrees C - 30 degrees C (59 degrees F - 86 degrees F).
For use in cattle as an aid in the treatment of
conditions associated with calcium, magnesium,
phosphorus, potassium or glucose deficiencies.
Cattle ....... 500 mL/800-1000 lbs body weight.
For intravenous administration only. Solution
should be warmed to body temperature and
administered slowly using aseptic precautions.
DO NOT administer this product to animals
showing signs of cardiac distress. Monitor animal's
condition closely.
Entire contents should be used when first entered
as this product contains no preservatives. Do not
use if solution is not clear. Discard any unused
portion.
Federal law restricts this drug to use by or on
the order of a licensed veterinarian.
For Animal Use Only
Keep Out of Reach of Children
NET CONTENTS: 500 mL (16.91 fl oz)
Dextrose.H2O ........................ 75.0 g
Calcium ................................ 10.8 g
(as calcium borogluconate)
Potassium ............................. 8.0 g
(as potassium chloride)
Phosphorus ........................... 2.5 g
(as sodium hypophosphite.H2O)
Magnesium ............................ 1.6 g
(as magnesium borogluconate)
Store between 15 degrees C - 30 degrees C (59 degrees F - 86 degrees F).
Calcium-Magnesium-Phosphorus-Potassium-Dextrose
STERILE
Distributed by:Aspen Veterinary Resources,R Ltd.
Liberty, MO 64068 USA A145NT 0 2/15
Manufactured by:
Nova-Tech, Inc.
Grand Island, NE 68801 USA
18-805
RMS # 92-502
Lot No. Exp. Date
TAKE TIME OBSERVE LABEL DIRECTIONS
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| POTASSIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0099355002807 | GTIN-13: 0099355002807 EAN-13: 0099355002807 GTIN-12: 099355002807 UPC-A: 099355002807 GTIN storage (14 digits): 00099355002807 | 92-502.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46066-805-50 | Cal Dex CMPK | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 9 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Calcium Gluconate Monohydrate | ACTIVE INGREDIENT | CZN0MI5R31 | 8 | |
| Dextrose monohydrate | ACTIVE INGREDIENT | LX22YL083G | 8 | |
| Magnesium Gluconate | ACTIVE INGREDIENT | T42NAD2KHC | 8 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 8 | |
| Potassium Chloride | ACTIVE INGREDIENT | 660YQ98I10 | 8 | |
| Anhydrous Dextrose | ACTIVE MOIETY | 5SL0G7R0OK | 8 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | 8 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 8 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 8 | |
| Potassium Cation | ACTIVE MOIETY | 295O53K152 | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 46066-805 | 46066-805-50 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dextrose monohydrate | LX22YL083G | ACTIB |
| Potassium Chloride | 660YQ98I10 | ACTIB |
| Calcium Gluconate Monohydrate | CZN0MI5R31 | ACTIB |
| Phosphorus | 27YLU75U4W | ACTIB |
| Magnesium Gluconate | T42NAD2KHC | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.